Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?
Authors:
- Nicolas RocheNRNicolas Roche
- Kenneth R. ChapmanKCKenneth R. Chapman
- Claus F. VogelmeierCVClaus F. Vogelmeier
- Felix J. F. HerthFHFelix J. F. Herth
- Chau ThachCTChau Thach
- Robert FogelRFRobert Fogel
- Petter OlssonPOPetter Olsson
- Francesco PatalanoFPFrancesco Patalano
- Donald BanerjiDBDonald Banerji
- Jadwiga A. WedzichaJWJadwiga A. Wedzicha
Open Access
- 1 November 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 196 (9) , 1230-1231
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME TrialAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysisInternational Journal of Chronic Obstructive Pulmonary Disease, 2017
- Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPDNew England Journal of Medicine, 2016
- Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialThe Lancet Respiratory Medicine, 2016
- Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPDThorax, 2015
- Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsThe Lancet Respiratory Medicine, 2015
- Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPDNew England Journal of Medicine, 2014